159C>T CD14 genotype—Functional effects on innate immune responses in term neonates

• Published in: Human immunology Vol. 69; no. 6; pp. 338 - 343
• Main Authors: Härtel, Christoph, Rupp, Jan, Hoegemann, Anne, Bohler, Annegret, Spiegler, Juliane, von Otte, Sören, Röder, Kathrin, Schultz, Christian, Göpel, Wolfgang
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-06-2008
• Subjects: 159C>T CD14 polymorphism; Allergy and Immunology; Cell Culture Techniques; Communicable Diseases - blood; Communicable Diseases - immunology; Female; Fetal Blood - cytology; Fetal Blood - immunology; Fetal Blood - metabolism; Gene Frequency; Genetic Predisposition to Disease; Genotype; Germany; Humans; Immunity, Innate - genetics; Infant; Infant, Newborn; Innate immune system; Interleukin-10 - blood; Interleukin-10 - genetics; Interleukin-10 - immunology; Interleukin-6; Interleukin-6 - blood; Interleukin-6 - genetics; Interleukin-6 - immunology; Lipopolysaccharide Receptors - blood; Lipopolysaccharide Receptors - genetics; Lipopolysaccharide Receptors - immunology; Male; Polymorphism, Single Nucleotide; Tumor Necrosis Factor-alpha - blood; Tumor Necrosis Factor-alpha - genetics; Tumor Necrosis Factor-alpha - immunology; Innate immune system; 159C>T CD14 polymorphism; Interleukin-6
• DOI: 10.1016/j.humimm.2008.04.011
• EISSN: 1879-1166
• ISSN: 0198-8859

Summary Given the susceptibility of newborns to infection and the potential harm of overwhelming proinflammatory immune responses, the impact of genetic variation in innate immune molecules is of increasing interest for risk stratification and prevention. We studied the functional relevance of the 159C>T CD14 single nucleotide polymorphism in cord blood samples of n = 135 healthy term neonates by investigation of sCD14, interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-α concentrations in whole-blood culture supernatants and intracellular assessment of IL-1β, IL-6, and TNF-α expression by flow cytometry. The 159C>T CD14 genotype frequencies were n = 42 (0.31) for homozygous CD14-159 CC, n = 69 (0.51) for heterozygous CD14-159 CT, and n = 24 (0.18) for homozygous CD14-159 TT. No genotype-associated differences were noted for ex vivo baseline expression of sCD14, IL-6, IL-10, and TNF-α. After in vitro stimulation of cord blood cultures with lipopolysaccharide, carriers of the CD14-159 T allele were determined to have higher levels of sCD14 compared with carriers of the CD14-159 C allele ( p = 0.04) and increased concentrations of IL-6 ( p = 0.009) in culture supernatants (one-way analysis of variance). The 159C>T CD14 polymorphism is associated with soluble CD14 expression and cytokine expression, which might influence the balance of pro- and anti-inflammatory immune responses in healthy term neonates. Further studies are needed to delineate whether the 159C>T CD14 genotype is a risk factor for severity of neonatal infection in the clinical setting and a potential target for prevention strategies.